Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    TopAbstracts in Rheumatoid Arthritis 11/27/2008 - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 11/13/2008 - (DGNews)
    Declining Benefit of Combination Therapy for Rheumatoid Arthritis Found in Long-Term Follow-Up of Patients: Presented at ACR-ARHP - (DGDispatch)
    Genetic Markers Point to Increased Risk of Infection in Patients With Rheumatoid Arthritis: Presented at ACR-ARHP - (DGDispatch)
    Efficacy of Rituximab Is Sustained in Patients With Rheumatoid Arthritis: Presented at ACR-ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
      B-Cell Biology and B-Cell-Targeted Therapies for Autoimmune Rheumatic Diseases: The Role of the Allied Health Professional
      Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases
      The Management of Difficult Rheumatoid Arthritis
      Expanding the Armamentarium for the Treatment of Juvenile Rheumatoid Arthritis: Update for Managed Care Pharmacists
      Hepatic Effects of Biologic Agents: Current and Future Issues in the Treatment of Rheumatoid Arthritis

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Adalimumab Induced Mononeuritis Multiplex in a Patient with Refractory Rheumatoid Arthritis: A Case Report
        Disseminated Cutaneous Herpes Simplex Virus-1 in a Patient with Rheumatoid Arthritis Receiving Infliximab: A Case Report
        Rheumatoid Nodule of the Thyrohyoid Membrane: A Case Report
        Recurrent Pneumothorax in a Patient with Rheumatoid Arthritis on Leflunomide Treatment: Case Report and Overview of the Literature
        Spontaneous Esophageal Perforation in a Patient with Achalasia Cardia and Rheumatoid Arthritis

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        A Clue To Rheumatoid Arthritis In Osteoprotegerin Expression?

        A DGReview of :"Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls."
        Rheumatology

        01/09/2003
        By Anne MacLennan


        A deficiency in osteoprotegerin (OPG) expression in the inflamed joint of rheumatoid arthritis patients with synovitis may be important in the development of radiologically defined joint erosions.

        This is the suggestion of an analysis of synovial tissue OPG expression in patients with rheumatoid arthritis (RA), spondyloarthropathies and osteoarthritis and in normal control subjects.

        In contrast to spondyloarthropathy patients with active synovitis, patients with RA and active synovitis have deficient OPG expression on both macrophage type synovial lining cells and endothelial cells, reports this multicentre study from Australia and the Netherlands.

        Led by Dr D R Haynes from the University of Adelaide, Adelaide, the investigators sought to demonstrate, in RA patients, the expression of OPG and receptor activator of nuclear factor kappaB ligand (RANKL) in synovial tissue. They also wanted to establish the cell lineage expressing OPG and compare the OPG expression in RA, spondyloarthropathies, osteoarthritis and normal synovial tissue.

        Synovial biopsy specimens were obtained by arthroscopy from 16 RA and 12 spondyloarthropathy patients with active synovitis of a knee joint, six RA patients with no evidence of active synovitis, 10 patients with osteoarthritis and 18 normal subjects.

        Immunohistological analysis was done using monoclonal antibodies (mAb) to detect OPG and RANKL expression, and dual immunohistochemical evaluation was done with lineage-specific monoclonal antibodies (macrophages, fibroblasts and endothelial cells) and OPG. This was to determine the cell lineages expressing OPG.

        Sections were evaluated by computer-assisted image analysis and semiquantitative analysis.

        Two patterns of OPG expression emerged, one exclusively in endothelial cells and one expressed predominantly in macrophages in the synovial lining layer. Both patterns of OPG staining could be blocked with excess recombinant OPG.

        In all synovial tissues except those from patients with active RA, there was endothelial and synovial lining OPG expression.

        In contrast to this, RANKL expression was seen predominantly in synovial tissue from patients with active disease, mainly in sublining regions, particularly within areas of lymphocyte infiltration.
        Rheumatology (Oxford) 2003 Jan;42(1):123-134. "Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send